CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA, LLC v. Watson Laboratories Inc.

1:13-cv-01015

Overview

Case Number 1:13-cv-01015
Filing Date 2013-06-06
Status Terminated
Termination Date 2014-09-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. Operating Company

Represented By

7 Attorneys Listed

Steven A. Maddox

Email: Steven.Maddox@procopio.com

Jonathan E. Bachand

Email: jonathan.bachand@knobbe.com

Jeremy J. Edwards

Email: Jeremy.Edwards@procopio.com

Daniel Kazhdan

Email: daniel.kazhdan@knobbe.com

Andrea L. Cheek

Email: Andrea.Cheek@knobbe.com

Collins J. Seitz , Jr.

Seitz Ross Aronstam & Moritz LLP

Tel: +1 (302) 576-1600

100 S. West Street, Suite 400, Wilmington, DE 19801

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Actavis Inc. Operating Company

Represented By

2 Attorneys Listed

Collins J. Seitz , Jr.

Seitz Ross Aronstam & Moritz LLP

Tel: +1 (302) 576-1600

100 S. West Street, Suite 400, Wilmington, DE 19801

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Fresenius Kabi USA, LLC Operating Company

Represented By

8 Attorneys Listed

Todd Marabella

Email: tmarabella@goodwinlaw.com

Sundar Subramanyam

Email: ssubramanyam@goodwinprocter.com

Samuel Sherry

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Laurie S. Gill

Email: lgill@goodwinprocter.com

John T. Bennett

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Jennifer L. Ford

Email: jford@goodwinprocter.com

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 18 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (18): 🇨🇦 Canada 🇩🇪 Germany 🇪🇺 Europe FR GB 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5714520
Propofol compostion containing edetate
Filed: 1995-03-22
Issued: 1998-02-03
Expired (Term Ended)
Expires: 2015-03-22
US5731355
Pharmaceutical compositions of propofol and edetate
Filed: 1997-02-18
Issued: 1998-03-24
Expired (Term Ended)
Expires: 2017-02-18
US5731356
Pharmaceutical compositions of propofol and edetate
Filed: 1997-02-18
Issued: 1998-03-24
Expired (Term Ended)
Expires: 2017-02-18
US5908869
Propofol compositions containing edetate
Filed: 1998-01-30
Issued: 1999-06-01
Expired (Term Ended)
Expires: 2018-01-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

11

Dispositive

0

Granted

1

Denied

1

Pending / Review

9

Motions by Category

Procedural / Extension Motion 10 Motion to Compel Discovery 1

Key Dispositive Motions & Rulings

Motion to Compel Discovery Granted
ORDER Granting Plaintiffs Letter/Motion to Compel (see D.I. 48 & 49 in 13-cv-00925-RGA, and 57 & 59 in 1:13-cv-01015-RGA). Signed by Judge Richard G. Andrews on...
Entry #60 • 2014-03-18 Document →
Procedural / Extension Motion Denied
ORDER Denying (D.I. 18 in 13-cv-00925-RGA, D.I. 17 in 13-cv-01015-RGA) MOTION For Leave to File Amended Complaint, filed by Fresenius Kabi USA, LLC. Signed by J...
Entry #52 • 2014-03-10 Document →
Procedural / Extension Motion Pending / Under Review
REQUEST for Oral Argument by Actavis Inc., Watson Laboratories Inc. re 17 MOTION to Amend/Correct Complaint. (Schladweiler, Benjamin) (Entered: 10/01/2013)
Entry #29 • 2013-10-01 Document →
Procedural / Extension Motion Pending / Under Review
[SEALED] REPLY BRIEF re 17 MOTION to Amend/Correct Complaint filed by Fresenius Kabi USA, LLC. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered...
Entry #28 • 2013-09-26 Document →
Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 24 Answering Brief in Opposition, Defendants' Opposition to Plaintiff's Motion for Leave to File Amended Complaint by Actavis Inc., Watson L...
Entry #26 • 2013-09-23 Document →
Procedural / Extension Motion Pending / Under Review
REDACTED VERSION of 25 Declaration, Declaration of Jeremy J. Edwards in Support of Defendants' Opposition to Plaintiff's Motion for Leave to File Amended Compla...
Entry #27 • 2013-09-23 Document →

Docket Entries

(101 total)
Pleading / Complaint

COMPLAINT - filed against Actavis Inc., Watson Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1304348.) - filed by Fresenius Kabi USA, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(rwc) (Entered: 06/06/2013)

Entry #1 • 2013-06-06
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/25/13. Date of Expiration of Patent: (5,714,520 = 9/22/15), (5,731,355 = 9/22/15), (5,731,356 = 9/22/15), (5,908,869 = 9/22/15).Thirty Month Stay Deadline: 10/25/2015. (rwc) (Entered: 06/06/2013)

Entry #2 • 2013-06-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (rwc) (Entered: 06/06/2013)

Entry #3 • 2013-06-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,714,520; 5,731,355; 5,731,356; 5,908,869. (rwc) (Entered: 06/06/2013)

Entry #4 • 2013-06-06
1
Pleading / Complaint

SUMMONS Returned Executed by Fresenius Kabi USA, LLC. Watson Laboratories Inc. served on 6/18/2013, answer due 7/9/2013. (Farnan, Brian) (Entered: 06/20/2013)

Entry #5 • 2013-06-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc